Trade BBOT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BridgeBio Oncology Therapeutics, Inc. (BBOT) is trading at US$4.77, down 2.45% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$727.98M. Over the past 52 weeks, BBOT has traded between US$4.69 and US$14.87. On Syfe you can trade BBOT with $0 commission and add it to your watchlist.
| Previous close | US$4.89 |
|---|---|
| Market cap | US$727.98M |
| 52-week range | US$4.69 – US$14.87 |
| Volume | 1.23M |
| Exchange | US |
Add to Watchlist
Set Price Alert
BridgeBio Oncology Therapeutics, Inc.
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Year: 2025
BridgeBio Oncology Q2 Loss Widens
Aug 11, 9:13 PM · MT Newswires
Canaccord Genuity Initiates BridgeBio Oncology Therapeutics at Buy
May 11, 11:59 AM · MT Newswires
BridgeBio Oncology Names CEO, COO, Executive Chairman
Apr 22, 2:27 PM · MT Newswires
BridgeBio Reports FDA Fast Track Label for BBO-11818
Apr 20, 9:20 PM · MT Newswires
BridgeBio Oncology Therapeutics, Inc. (BBOT) stock is trading at US$4.77, -2.45% from the previous close of US$4.89.
The market cap for BridgeBio Oncology Therapeutics, Inc. (BBOT) stock is approximately US$727.98M.
The 52-week high for BridgeBio Oncology Therapeutics, Inc. (BBOT) stock is US$14.87.
The 52-week low for BridgeBio Oncology Therapeutics, Inc. (BBOT) stock is US$4.69.
BridgeBio Oncology Therapeutics, Inc. (BBOT) does not currently pay a dividend.
Stay on top of BBOT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
